Amgen gives confidence to investors on pending purchase | Pacific Coast Business Times
Thousand Oaks-based Amgen beat analysts’ expectations when it reported its earnings for the second quarter on Aug. 3, but more importantly, the company reaffirmed its position that it can close the pending acquisition of Horizon Therapeutics before the end of the year. The biotech giant reported net income grew 4.5% year over year from $1.32